These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
194 related items for PubMed ID: 7505257
1. Co-stimulation with B7 and targeted superantigen is required for MHC class II-independent T-cell proliferation but not cytotoxicity. Lando PA, Dohlsten M, Hedlund G, Brodin T, Sansom D, Kalland T. Immunology; 1993 Oct; 80(2):236-41. PubMed ID: 7505257 [Abstract] [Full Text] [Related]
2. Regulation of superantigen-induced T cell activation in the absence and the presence of MHC class II. Lando PA, Olsson C, Kalland T, Newton D, Kotb M, Dohlsten M. J Immunol; 1996 Oct 01; 157(7):2857-63. PubMed ID: 8816390 [Abstract] [Full Text] [Related]
3. Proliferation of human T lymphocytes induced with superantigens is not dependent on costimulation by the CD28 counter-receptor B7. Damle NK, Klussman K, Leytze G, Linsley PS. J Immunol; 1993 Feb 01; 150(3):726-35. PubMed ID: 7678619 [Abstract] [Full Text] [Related]
4. Antibody-targeted superantigens induce lysis of major histocompatibility complex class II-negative T-cell leukemia lines. Ihle J, Holzer U, Krull F, Dohlsten M, Kalland T, Niethammer D, Dannecker GE. Cancer Res; 1995 Feb 01; 55(3):623-8. PubMed ID: 7530598 [Abstract] [Full Text] [Related]
5. Superantigen and HLA-DR ligation induce phospholipase-C gamma 1 activation in class II+ T cells. Kanner SB, Odum N, Grosmaire L, Masewicz S, Svejgaard A, Ledbetter JA. J Immunol; 1992 Dec 01; 149(11):3482-8. PubMed ID: 1385526 [Abstract] [Full Text] [Related]
6. B7/CD28 but not LFA-3/CD2 interactions can provide 'third-party' co-stimulation for human T-cell activation. Sansom DM, Wilson A, Boshell M, Lewis J, Hall ND. Immunology; 1993 Oct 01; 80(2):242-7. PubMed ID: 7505258 [Abstract] [Full Text] [Related]
11. Dissection of the function of HLA class II and costimulation in B cell-mediated and toxic shock syndrome toxin-1-induced T cell proliferation. Dennig D, O'Reilly RJ. J Immunol; 1993 Jun 15; 150(12):5231-40. PubMed ID: 7685791 [Abstract] [Full Text] [Related]
13. Expression of a variant of CD28 on a subpopulation of human NK cells: implications for B7-mediated stimulation of NK cells. Galea-Lauri J, Darling D, Gan SU, Krivochtchapov L, Kuiper M, Gäken J, Souberbielle B, Farzaneh F. J Immunol; 1999 Jul 01; 163(1):62-70. PubMed ID: 10384100 [Abstract] [Full Text] [Related]
14. CD28 delivers costimulatory signals for superantigen-induced activation of antigen-presenting cell-depleted human T lymphocytes. Ohnishi H, Tanaka T, Takahara J, Kotb M. J Immunol; 1993 Apr 15; 150(8 Pt 1):3207-14. PubMed ID: 7682235 [Abstract] [Full Text] [Related]
15. Immunopharmacology of the superantigen staphylococcal enterotoxin A in T-cell receptor V beta 3 transgenic mice. Dohlsten M, Björklund M, Sundstedt A, Hedlund G, Samson D, Kalland T. Immunology; 1993 Aug 15; 79(4):520-7. PubMed ID: 7691731 [Abstract] [Full Text] [Related]
16. T-cell presentation of antigen requires cell-to-cell contact for proliferation and anergy induction. Differential MHC requirements for superantigen and autoantigen. LaSalle JM, Toneguzzo F, Saadeh M, Golan DE, Taber R, Hafler DA. J Immunol; 1993 Jul 15; 151(2):649-57. PubMed ID: 7687620 [Abstract] [Full Text] [Related]
17. Simultaneous ligation of CD5 and CD28 on resting T lymphocytes induces T cell activation in the absence of T cell receptor/CD3 occupancy. Verwilghen J, Vandenberghe P, Wallays G, de Boer M, Anthony N, Panayi GS, Ceuppens JL. J Immunol; 1993 Feb 01; 150(3):835-46. PubMed ID: 7678624 [Abstract] [Full Text] [Related]
18. Accessory cell function of keratinocytes for superantigens. Dependence on lymphocyte function-associated antigen-1/intercellular adhesion molecule-1 interaction. Nickoloff BJ, Mitra RS, Green J, Zheng XG, Shimizu Y, Thompson C, Turka LA. J Immunol; 1993 Mar 15; 150(6):2148-59. PubMed ID: 8450207 [Abstract] [Full Text] [Related]
19. Monoclonal antibody-targeted superantigens: a different class of anti-tumor agents. Dohlsten M, Hedlund G, Akerblom E, Lando PA, Kalland T. Proc Natl Acad Sci U S A; 1991 Oct 15; 88(20):9287-91. PubMed ID: 1924393 [Abstract] [Full Text] [Related]